Table 3 Statistical comparison between pre-treatment and post-treatment parameters in glycemic improved patients

Hemoglobin (g/dL)^a

13.07 ± 1.05

12.57 ± 1.23

0.002

Leukocytes (× 103/μL cells)^a

6.53 ± 1.91

6.58 ± 2.03

0.876

Platelets (× 103/μL cells)^a

206.56 ± 53.82

217.31 ± 47.82

0.130

Albumin (g/dL)^a

4.30 ± 0.40

4.31 ± 0.37

0.501

Bilirubin, total (mg/dL)^a

0.78 ± 0.22

0.67 ± 0.19

0.009

INR^a

1.41 ± 1.75

1.07 ± 0.09

0.290

AST (IU/L)^a

51.59 ± 28.20

24.53 ± 8.27

0.001

ALT (IU/L)^a

64.13 ± 35.90

24.22 ± 7.98

0.001

Creatinine (mg/dL)^a

0.87 ± 0.15

0.88 ± 0.15

0.525

HbA1c (%)^a

7.91 ± 0.69

6.50 ± 0.72

0.001

AFP (ng/mL)^a

7.41 ± 6.24

6.56 ± 5.94

0.032

FIB-4^b score^a

1.75 ± 0.76

1.17 ± 0.44

0.001